Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
rosuvastatine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
|
Product containing precisely rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
|
Product containing precisely rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
|
Rosuvastatin (as rosuvastatin calcium) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
|
Rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
|
Product containing precisely rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Rosuvastatin (as rosuvastatin calcium) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Rosuvastatin (as rosuvastatin calcium) 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 67 milligram and rosuvastatin (as rosuvastatin calcium) 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rosuvastatin calcium (substance) |
Inferred relationship |
Some |
2 |